Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 7, 2002, Pages 2287-2291

  Solbrig, Marylou V ^a   Schlaberg, Robert ^a   Briese, Thomas ^a   Horscroft, Nigel ^a   Lipkin, W Ian ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN; ANTIVIRUS AGENT; CYTOKINE; MESSENGER RNA; NEUROPROTECTIVE AGENT; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORNA DISEASE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; MICROGLIA; MORBIDITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; VIRUS LOAD; ANIMAL; BORNA DISEASE VIRUS; BRAIN; CELL DIVISION; CYTOLOGY; GENETICS; IMMUNOLOGY; LEWIS RAT; METABOLISM; PATHOLOGY; T LYMPHOCYTE; VIROLOGY;

ANIMAL; ANTIVIRAL AGENTS; BORNA DISEASE; BORNA DISEASE VIRUS; BRAIN; CELL DIVISION; CYTOKINES; MALE; MICROGLIA; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED LEW; RIBAVIRIN; RNA, MESSENGER; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; ANIMALS;

EID: 0035984830     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.7.2287-2291.2002     Document Type: Article

References (47)

1. Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin
2. Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression
3. Borna virus infections in cattle associated with fatal neurological disease
4. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: A multicenter trial
5. An enzyme-linked-immunosorbent assay for detecting antibodies to Borna disease virus-specific proteins
6. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon
7. Ribavirin: A review of efficacy, toxicity and mechanisms of antiviral activity
8. Borna disease in naturally infected cattle
9. Pathogenesis of Borna disease in rats: Evidence that intra-axonal spread is the major route for virus dissemination and the determinant for disease incubation
10. Mechanism of La Crosse virus inhibition by ribavirin
11. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen
12. Amantadine does not have antiviral activity against Borna disease virus
13. Borna disease in a free-ranging lynx (Lynx lynx)
14. Word recognition memory before and after successful treatment of depression
15. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate
16. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans: Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors
17. Amantadine revisited: An open trial of amantadine sulfate treatment in chronically depressed patients with Borna disease virus infection
18. Minireview: Biochemistry and clinical applications of ribavirin
19. The broad spectrum antiviral agent ribavirin inhibits capping of mRNA
20. Borna disease virus RNA in peripheral blood mononuclear cells obtained from healthy dairy cattle
21. Borna disease virus is not sensitive to amantadine
22. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses
23. Purification, chain separation and sequence of the MRC OX-8 antigen, a marker of rat cytotoxic T lymphocytes
24. Inhibition of Borna disease virus replication by ribavirin
25. Effect of immune priming on Borna disease
26. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection
27. Borna disease: A persistent virus infection of the central nervous system
28. Natural Borna disease in domestic animals others than horses and sheep
29. Borna disease in ostriches
30. Natural Borna virus infection in rabbits
31. Inhibition of Borna disease virus replication by ribavirin in persistently infected cells
32. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response
33. Focus-immunoassay for Borna disease virus-specific antigens
34. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3
35. Tardive dyskinetic syndrome in rats infected with Borna disease virus
36. Behavioral disturbances and pharmacology of Borna disease
37. Behavior alterations in tree shrews (Tupaia glis, Diard 1820) induced by Borna disease virus
38. Borna disease in rhesus monkeys as a model for uveo-cerebral symptoms
39. Lack of antiviral effect of amantadine in Borna disease virus infection
40. Mechanism of action of 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent
41. Ribavirin polarizes human T cell responses towards a type 1 cytokine profile
42. Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription
43. Borna disease in a dog with lethal meningoencephalitis
44. T-lymphocyte heterogeneity in the rat: Separation of functional subpopulations using a monoclonal antibody
45. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro